Association between CEBPE variant and childhood acute leukemia risk: Evidence from a meta-analysis of 22 studies

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Sun, Jian ^a   Zheng, Jinyu ^b   Tang, Linjun ^c   Healy, Jasmine ^d   Sinnett, Daniel ^d,e   Dai, Yue E ^f  

^a Huai'an Maternal and Child Health Care Center   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c Tongling People's Hospital   (China)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN EPSILON; CCAAT ENHANCER BINDING PROTEIN; CEBPE PROTEIN, HUMAN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLELE; ARTICLE; ASIAN; B CELL LEUKEMIA; BIBLIOGRAPHIC DATABASE; CANCER RISK; CASE CONTROL STUDY; CEBPE GENE; CHILDHOOD LEUKEMIA; ETHNIC DIFFERENCE; EUROPEAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LEUKEMOGENESIS; RISK REDUCTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; T CELL LEUKEMIA; ACUTE DISEASE; AGE; CHILD; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOTYPE; LEUKEMIA; META ANALYSIS; ODDS RATIO; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE DISEASE; AGE FACTORS; ALLELES; CCAAT-ENHANCER-BINDING PROTEINS; CHILD; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LEUKEMIA; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84929193389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125657     Document Type: Article

References (40)

1. Pui CH. Childhood leukemias. The New England journal of medicine. 1995; 332(24):1618-30. Epub 1995/06/15. doi: 10.1056/NEJM199506153322407 PMID: 7753142.
2. Schmiegelow K, Vestergaard T, Nielsen SM, Hjalgrim H. Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis. Leukemia. 2008; 22(12):2137-41. Epub 2008/08/23. doi: 10.1038/leu.2008.212 PMID: 18719616.
3. Wiemels J. Perspectives on the causes of childhood leukemia. Chemico-biological interactions. 2012; 196(3):59-67. Epub 2012/02/14. doi: 10.1016/j.cbi.2012.01.007 PMID: 22326931; PubMed Central PMCID: PMC3839796.
4. Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005; 23(26):6306-15. Epub 2005/09/13. doi: 10.1200/JCO.2005.05.047 PMID: 16155013.
5. Akagi T, Thoennissen NH, George A, Crooks G, Song JH, Okamoto R, et al. In vivo deficiency of both C/EBPbeta and C/EBPepsilon results in highly defective myeloid differentiation and lack of cytokine response. PloS one. 2010; 5(11):e15419. Epub 2010/11/13. doi: 10.1371/journal.pone.0015419 PMID: 21072215; PubMed Central PMCID: PMC2972224.
6. Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. Journal of the National Cancer Institute. 2013; 105(10):733-42. Epub 2013/03/21. doi: 10.1093/jnci/djt042 PMID: 23512250; PubMed Central PMCID: PMC3691938.
7. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nature genetics. 2009; 41(9):1006-10. Epub 2009/08/18. doi: 10.1038/ng.430 PMID: 19684604.
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002; 21(11):1539-58. Epub 2002/07/12. doi: 10.1002/sim.1186 PMID: 12111919.
9. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. Journal of clinical epidemiology. 2008; 61(7):634-45. Epub 2008/06/10. doi: 10.1016/j.jclinepi.2007.12.011 PMID: 18538260.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7(3):177-88. Epub 1986/09/01. PMID: 3802833.
11. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Statistics in medicine. 1988; 7(8):889-94. Epub 1988/08/01. PMID: 3413368.
12. Lu XC, Yu W, Tao Y, Zhao PL, Li K, Tang LJ, et al. Contribution of transforming growth factor alpha polymorphisms to nonsyndromic orofacial clefts: a HuGE review and meta-analysis. American journal of epidemiology. 2014; 179(3):267-81. Epub 2013/11/19. doi: 10.1093/aje/kwt262 PMID: 24243742.
13. Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics. 2000; 1(3):247-62. Epub 2003/08/23. doi: 10.1093/biostatistics/1.3.247 PMID: 12933507.
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. Epub 1997/10/06. PMID: 9310563; PubMed Central PMCID: PMC2127453.
15. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. Epub 1994/12/01. PMID: 7786990.
16. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. Epub 2000/07/06. PMID: 10877304.
17. Emerenciano M, Barbosa TC, Lopes BA, Blunck CB, Faro A, Andrade C, et al. ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia. BMC cancer. 2014; 14:127. Epub 2014/02/26. doi: 10.1186/1471-2407-14-127 PMID: 24564228; PubMed Central PMCID: PMC3948138.
18. Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, te Kronnie G, Cario G, et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia. 2012; 26(5):902-9. Epub 2011/11/15. doi: 10.1038/leu.2011.302 PMID: 22076464; PubMed Central PMCID: PMC3356560.
19. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 2010; 115(9):1765-7. Epub 2010/01/01. doi: 10.1182/blood-2009-09-241513 PMID: 20042726.
20. Ross JA, Linabery AM, Blommer CN, Langer EK, Spector LG, Hilden JM, et al. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatric blood & cancer. 2013; 60(1):31-4. Epub 2012/03/17. doi: 10.1002/pbc.24131 PMID: 22422485; PubMed Central PMCID: PMC3381932.
21. Vijayakrishnan J, Sherborne AL, Sawangpanich R, Hongeng S, Houlston RS, Pakakasama S. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leukemia & lymphoma. 2010; 51(10):1870-4. Epub 2010/10/06. doi: 10.3109/10428194.2010.511356 PMID: 20919861.
22. Orsi L, Rudant J, Bonaventure A, Goujon-Bellec S, Corda E, Evans TJ, et al. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia. 2012; 26(12):2561-4. Epub 2012/06/05. doi: 10.1038/leu.2012.148 PMID: 22660188.
23. Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R, et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 2007; 109(8):3451-61. Epub 2006/12/16. doi: 10.1182/blood-2006-08-041012 PMID: 17170124.
24. Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica. 2010; 95(9):1608-11. Epub 2010/05/13. doi: 10.3324/haematol.2010.022459 PMID: 20460642; PubMed Central PMCID: PMC2930966.
25. Pastorczak A, Gorniak P, Sherborne A, Hosking F, Trelinska J, Lejman M, et al. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leukemia research. 2011; 35(11):1534-6. Epub 2011/09/06. doi: 10.1016/j.leukres.2011.07.034 PMID: 21889209.
26. Li S, Ren L, Fan L, Wang G. IKZF1 rs4132601 polymorphism and acute lymphoblastic leukemia susceptibility: a meta-analysis. Leukemia & lymphoma. 2014:1-13. Epub 2014/07/12. doi: 10.3109/10428194.2014.939965 PMID: 25012940.
27. He J, Wang F, Zhu JH, Chen W, Cui Z, Jia WH. No association between MTR rs1805087 A>G polymorphism and non-Hodgkin lymphoma susceptibility: Evidence from 11486 subjects. Leukemia & lymphoma. 2014:1-23. Epub 2014/06/24. doi: 10.3109/10428194.2014.935370 PMID: 24956146.
28. Lim JY, Bhatia S, Robison LL, Yang JJ. Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer. 2014; 120(7):955-62. Epub 2014/01/03. doi: 10.1002/cncr.28531 PMID: 24382716; PubMed Central PMCID: PMC4015138.
29. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012; 119(1):34-43. Epub 2011/11/17. doi: 10.1182/blood-2011-04-347872 PMID: 22086414; PubMed Central PMCID: PMC3251235.
30. Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood. 2002; 100(6):1957-64. Epub 2002/08/30. doi: 10.1182/blood-2002-02-0395 PMID: 12200352.
31. Wang C, Chen J, Sun H, Sun L, Liu Y. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls. Annals of hematology. 2015; 94(2):181-5. Epub 2014/09/10. doi: 10.1007/s00277-014-2186-x PMID: 25195121.
32. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nature reviews Cancer. 2006; 6(3):193-203. Epub 2006/02/10. doi: 10.1038/nrc1816 PMID: 16467884.
33. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013; 381(9881):1943-55. Epub 2013/03/26. doi: 10.1016/S0140-6736(12)62187-4 PMID: 23523389; PubMed Central PMCID: PMC3816716.
34. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2012; 30(14):1663-9. Epub 2012/03/14. doi: 10.1200/JCO.2011.37.8018 PMID: 22412151; PubMed Central PMCID: PMC3383113.
35. Rubnitz JE. How I treat pediatric acute myeloid leukemia. Blood. 2012; 119(25):5980-8. Epub 2012/05/09. doi: 10.1182/blood-2012-02-392506 PMID: 22566607; PubMed Central PMCID: PMC3383013.
36. Gibson BE, Webb DK, Howman AJ, De Graaf SS, Harrison CJ, Wheatley K. Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. British journal of haematology. 2011; 155(3):366-76. Epub 2011/09/10. doi: 10.1111/j.1365-2141.2011.08851.x PMID: 21902686.
37. Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. The Lancet Oncology. 2010; 11(6):543-52. Epub 2010/05/11. doi: 10.1016/S1470-2045(10)70090-5 PMID: 20451454; PubMed Central PMCID: PMC3171799.
38. Tang Q, Li J, Zhang S, Yuan B, Sun H, Wu D, et al. GSTM1 and GSTT1 null polymorphisms and childhood acute leukemia risk: evidence from 26 case-control studies. PloS one. 2013; 8(10):e78810. Epub 2013/11/07. doi: 10.1371/journal.pone.0078810 PMID: 24194954; PubMed Central PMCID: PMC3806859.
39. Qin L, Chen X, Li P, Yang Z, Mo W. Comprehensive assessment of the association between DNA repair gene XRCC3 Thr241Met polymorphism and leukemia risk. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35(3):2521-8. Epub 2013/11/08. doi: 10.1007/s13277-013-1333-7 PMID: 24197983.
40. Wang Y, Chen J, Li J, Deng J, Rui Y, Lu Q, et al. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. Gene. 2013; 524(2):203-7. Epub 2013/04/24. doi: 10.1016/j.gene.2013.04.028 PMID: 23608171.